Literature DB >> 17068147

Early CD30 signaling is critical for adoptively transferred CD4+CD25+ regulatory T cells in prevention of acute graft-versus-host disease.

Robert Zeiser1, Vu H Nguyen, Jing-Zhou Hou, Andreas Beilhack, Elizabeth Zambricki, Martin Buess, Christopher H Contag, Robert S Negrin.   

Abstract

Murine CD4+CD25+ regulatory T cells (Treg cells) reduce acute graft-versus-host disease (aGvHD). However, surface molecules critical for suppression are unclear. Deficiency of CD30 (CD30-/-) leads to impaired thymic negative selection and augmented T-cell autoreactivity. Therefore, we investigated the role of CD30 signaling in Treg-cell function during aGvHD. Treg cells derived from CD30-/- animals were significantly less effective in preventing aGvHD lethality. Early blockade of the CD30/CD153 pathway with a neutralizing anti-CD153 mAb reduced Treg-mediated protection from proinflammatory cytokine accumulation and donor-type T-cell apoptosis. In vivo bioluminescence imaging demonstrated intact homing but reduced expansion of luciferase-expressing Treg cells when CD153 was blocked during the early phase after adoptive transfer. CD30 surface expression on Treg cells increased with alloantigen exposure, and CD153 expression on recipient-type dendritic cells increased in the presence of a proinflammatory environment. These data demonstrate that early CD30 signaling is critical for Treg-mediated aGvHD protection after major MHC-mismatch bone marrow transplantation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17068147      PMCID: PMC1801065          DOI: 10.1182/blood-2006-07-038455

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  43 in total

1.  Identification of a previously unknown antigen-specific regulatory T cell and its mechanism of suppression.

Authors:  Z X Zhang; L Yang; K J Young; B DuTemple; L Zhang
Journal:  Nat Med       Date:  2000-07       Impact factor: 53.440

2.  Human CD4+ T lymphocytes with remarkable regulatory functions on dendritic cells and nickel-specific Th1 immune responses.

Authors:  A Cavani; F Nasorri; C Prezzi; S Sebastiani; C Albanesi; G Girolomoni
Journal:  J Invest Dermatol       Date:  2000-02       Impact factor: 8.551

3.  Control of homeostatic proliferation by regulatory T cells.

Authors:  Shiqian Shen; Yi Ding; Carlos E Tadokoro; Danyvid Olivares-Villagómez; Marlin Camps-Ramírez; Maria A Curotto de Lafaille; Juan J Lafaille
Journal:  J Clin Invest       Date:  2005-11-17       Impact factor: 14.808

4.  Activated CD4+CD25+ T cells selectively kill B lymphocytes.

Authors:  Dong-Mei Zhao; Angela M Thornton; Richard J DiPaolo; Ethan M Shevach
Journal:  Blood       Date:  2006-01-17       Impact factor: 22.113

Review 5.  In vivo imaging using bioluminescence: a tool for probing graft-versus-host disease.

Authors:  Robert S Negrin; Christopher H Contag
Journal:  Nat Rev Immunol       Date:  2006-06       Impact factor: 53.106

6.  Critical role for CCR5 in the function of donor CD4+CD25+ regulatory T cells during acute graft-versus-host disease.

Authors:  Christian A Wysocki; Qi Jiang; Angela Panoskaltsis-Mortari; Patricia A Taylor; Karen P McKinnon; Lishan Su; Bruce R Blazar; Jonathan S Serody
Journal:  Blood       Date:  2005-07-07       Impact factor: 22.113

7.  In vivo analyses of early events in acute graft-versus-host disease reveal sequential infiltration of T-cell subsets.

Authors:  Andreas Beilhack; Stephan Schulz; Jeanette Baker; Georg F Beilhack; Courtney B Wieland; Edward I Herman; Enosh M Baker; Yu-An Cao; Christopher H Contag; Robert S Negrin
Journal:  Blood       Date:  2005-04-26       Impact factor: 22.113

8.  CD30+ T cells in rheumatoid synovitis: mechanisms of recruitment and functional role.

Authors:  R Gerli; C Pitzalis; O Bistoni; B Falini; V Costantini; A Russano; C Lunardi
Journal:  J Immunol       Date:  2000-04-15       Impact factor: 5.422

Review 9.  CD30: expression and function in health and disease.

Authors:  R Horie; T Watanabe
Journal:  Semin Immunol       Date:  1998-12       Impact factor: 11.130

10.  Inhibition of CD4+CD25+ regulatory T-cell function by calcineurin-dependent interleukin-2 production.

Authors:  Robert Zeiser; Vu H Nguyen; Andreas Beilhack; Martin Buess; Stephan Schulz; Jeanette Baker; Christopher H Contag; Robert S Negrin
Journal:  Blood       Date:  2006-03-07       Impact factor: 22.113

View more
  30 in total

1.  Expression of CD30 in patients with acute graft-versus-host disease.

Authors:  Yi-Bin Chen; Sean McDonough; Robert Hasserjian; Heidi Chen; Erin Coughlin; Christina Illiano; In Sun Park; Madan Jagasia; Thomas R Spitzer; Corey S Cutler; Robert J Soiffer; Jerome Ritz
Journal:  Blood       Date:  2012-06-01       Impact factor: 22.113

2.  Deficiency of CD73/ecto-5'-nucleotidase in mice enhances acute graft-versus-host disease.

Authors:  Hiroki Tsukamoto; Petya Chernogorova; Korcan Ayata; Ulrike V Gerlach; Ankur Rughani; Jerry W Ritchey; Jayanthi Ganesan; Marie Follo; Robert Zeiser; Linda F Thompson; Marco Idzko
Journal:  Blood       Date:  2012-01-18       Impact factor: 22.113

Review 3.  Advances in bioluminescence imaging of live animal models.

Authors:  Robin S Dothager; Kelly Flentie; Britney Moss; Mei-Hsiu Pan; Aparna Kesarwala; David Piwnica-Worms
Journal:  Curr Opin Biotechnol       Date:  2009-02-23       Impact factor: 9.740

4.  Impact of mammalian target of rapamycin inhibition on lymphoid homing and tolerogenic function of nanoparticle-labeled dendritic cells following allogeneic hematopoietic cell transplantation.

Authors:  Wilfried Reichardt; Christoph Dürr; Dominik von Elverfeldt; Eva Jüttner; Ulrike V Gerlach; Mayumi Yamada; Benjie Smith; Robert S Negrin; Robert Zeiser
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

5.  Amino acid copolymer-specific IL-10-secreting regulatory T cells that ameliorate autoimmune diseases in mice.

Authors:  Joel N H Stern; Derin B Keskin; Hong Zhang; Huijuan Lv; Zenichiro Kato; Jack L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-24       Impact factor: 11.205

6.  Human Dendritic Cells Mitigate NK-Cell Dysfunction Mediated by Nonselective JAK1/2 Blockade.

Authors:  Shane A Curran; Justin A Shyer; Erin T St Angelo; Lillian R Talbot; Sneh Sharma; David J Chung; Glenn Heller; Katharine C Hsu; Brian C Betts; James W Young
Journal:  Cancer Immunol Res       Date:  2016-12-06       Impact factor: 11.151

7.  Progressive multifocal leukoencephalopathy associated with brentuximab vedotin therapy: a report of 5 cases from the Southern Network on Adverse Reactions (SONAR) project.

Authors:  Kenneth R Carson; Scott D Newsome; Ellen J Kim; Nina D Wagner-Johnston; Gloria von Geldern; Craig H Moskowitz; Alison J Moskowitz; Alain H Rook; Pankaj Jalan; Alison W Loren; Daniel Landsburg; Thomas Coyne; Donald Tsai; Dennis W Raisch; LeAnn B Norris; P Brandon Bookstaver; Oliver Sartor; Charles L Bennett
Journal:  Cancer       Date:  2014-04-25       Impact factor: 6.860

Review 8.  Molecular mechanisms of T cell co-stimulation and co-inhibition.

Authors:  Lieping Chen; Dallas B Flies
Journal:  Nat Rev Immunol       Date:  2013-03-08       Impact factor: 53.106

9.  Bioluminescence-based visualization of CD4 T cell dynamics using a T lineage-specific luciferase transgenic model.

Authors:  Joseph H Chewning; Kari J Dugger; Tandra R Chaudhuri; Kurt R Zinn; Casey T Weaver
Journal:  BMC Immunol       Date:  2009-08-03       Impact factor: 3.615

Review 10.  Heat shock protein 60 reactive T cells in juvenile idiopathic arthritis: what is new?

Authors:  Yvonne Vercoulen; Nienke H van Teijlingen; Ismé M de Kleer; Sylvia Kamphuis; Salvatore Albani; Berent J Prakken
Journal:  Arthritis Res Ther       Date:  2009-05-19       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.